Logo image
Functional and potentially adaptive role of polyglutamine in S. cerevisiae Med15
Dissertation   Open access

Functional and potentially adaptive role of polyglutamine in S. cerevisiae Med15

David George Cooper
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Summer 2021
DOI: 10.17077/etd.005935
pdf
David Cooper Thesis 08032113.12 MBDownloadView
Open Access Free to read and download

Abstract

Cells can respond to stress and changing environments by altering gene expression. The RNA Polymerase II Mediator is a conserved eukaryotic protein complex which mediates expression of target genes through recruitment of RNA Polymerase II to promoters of target genes. Med15, a subunit of the Mediator complex, is located at a critical position in the complex where it is responsible for interacting with DNA-bound signal-specific transcription factors. The wide array of phenotypic defects in Saccharomyces cerevisiae yeast cells in which MED15 has been deleted reflect the role of Med15 in regulating stress response genes as well as genes involved in the metabolism of diverse biomolecules. Med15 is intrinsically disordered and glutamine-rich with three polyglutamine tracts that vary in length among strains. The variation in length (number of glutamines) is due to the instability of the underlying repetitive DNA sequences. In some proteins, expansion of the polyglutamine tracts beyond a threshold length causes neurodegenerative disease. Despite the potential risk of disease-causing expansions, polyglutamine tracts are surprisingly prevalent in eukaryotic proteomes and are specifically enriched in transcriptional regulators, suggesting that polyglutamine tracts are involved in modulating gene expression. My work focuses on understanding how the intrinsic disorder and glutamine-rich nature of Med15 influences the activity of the protein in yeast. My approach included computational analyses of MED15 sequence variation across yeast strains and non-fungal eukaryotes, an analysis of the functional consequences of natural and synthetic variation in MED15 polyglutamine tracts, and analysis of commercial alcoholic fermentation associated MED15 alleles. I found that the three polyglutamine tracts within Med15 are highly variable in length and that while a significant amount of tract length variability is tolerated, the transcriptional regulation activity of Med15 varies with polyglutamine tract length. My studies show that many naturally occurring combinations of polyglutamine tract lengths allow Med15 to function normally, but that hybrid genes with engineered (non-natural) combinations of glutamine tracts have impaired function. Results of my studies support a role for polyglutamine tract length variation in facilitating adaptation to the grape juice fermentation environment. I found that natural MED15 alleles acquired from commercial alcoholic fermentation yeast strains with polyglutamine tract length polymorphisms exhibit improved fermentation phenotypes and enhanced expression of fermentation genes. Finally, my work begins to describe the Med15 features that are conserved across eukaryotes, including an enrichment of disorder-promoting residues instead of conserved primary sequence. I found that non-fungal Med15 orthologs fail to complement defects in the S. cerevisiae med15 mutant and that even fungal orthologs only partially complement med15 phenotypes. This suggests that the conserved disorder does not correspond directly to conserved function. Instead, I propose that the intrinsic disorder of Med15 has permitted Med15 to diverge alongside existing and novel interacting transcription factors. My findings are consistent with a role for the glutamine-rich nature of Med15 in two important ways: allowing adaptation of closely related strains to new environments and allowing for malleability in diverging organisms.
Fermentation Transcription Bioinformatics Med15 Mediator complex Polyglutamine

Details

Metrics

24 File views/ downloads
48 Record Views
Logo image